Retatrutide
FeaturedA triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
AOD-9604 is a synthetic peptide fragment of human growth hormone, engineered to retain fat-burning properties without promoting tissue growth or elevated blood sugar. It is studied for its potential role in weight loss and metabolism regulation.
In the literature, AOD-9604 appears most often in work focused on fat loss, weight loss and metabolism. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, AOD-9604 also shows up in discussions of appetite control. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
An NNMT inhibitor studied for increasing cellular metabolism, reducing fat mass, and preserving muscle during weight loss research.
A modified fragment of human growth hormone studied specifically for fat metabolism without affecting blood sugar or growth.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.